NDFIP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.984200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.881180E-01
Normal-vs-Stage2
9.934000E-01
Normal-vs-Stage3
2.610600E-01
Normal-vs-Stage4
5.435000E-01
Stage1-vs-Stage2
7.194300E-04
Stage1-vs-Stage3
3.278200E-02
Stage1-vs-Stage4
3.342200E-01
Stage2-vs-Stage3
1.770360E-01
Stage2-vs-Stage4
3.032800E-01
Stage3-vs-Stage4
1.019230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.989000E-01
Normal-vs-AfricanAmerican
7.091400E-01
Normal-vs-Asian
8.207400E-01
Caucasian-vs-AfricanAmerican
9.318800E-01
Caucasian-vs-Asian
4.000800E-01
AfricanAmerican-vs-Asian
4.514400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.925000E-01
Normal-vs-Female
8.055400E-01
Male-vs-Female
7.251600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.376200E-01
Normal-vs-Age(41-60Yrs)
4.590600E-01
Normal-vs-Age(61-80Yrs)
9.338400E-01
Normal-vs-Age(81-100Yrs)
5.351400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.057200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.068200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.668600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.296100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.738480E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.519030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.180600E-01
Normal-vs-Daily Drinker
8.955400E-01
Normal-vs-Weekly Drinker
5.635000E-01
Normal-vs-Occasional Drinker
4.860000E-01
Normal-vs-Social Drinker
7.147800E-01
Non Drinker-vs-Daily Drinker
4.478200E-01
Non Drinker-vs-Weekly Drinker
5.517400E-01
Non Drinker-vs-Occasional Drinker
6.224100E-02
Non Drinker-vs-Social Drinker
2.922800E-01
Daily Drinker-vs-Weekly Drinker
2.613800E-01
Daily Drinker-vs-Occasional Drinker
1.829160E-01
Daily Drinker-vs-Social Drinker
5.375800E-01
Weekly Drinker-vs-Occasional Drinker
3.153800E-02
Weekly Drinker-vs-Social Drinker
1.747400E-01
Occasional Drinker-vs-Social Drinker
6.103400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.689020E-01
Normal-vs-Grade 2
1.276380E-03
Normal-vs-Grade 3
4.155100E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.758380E-01
Grade 1-vs-Grade 3
1.540360E-01
Grade 1-vs-Grade 4
1.689020E-01
Grade 2-vs-Grade 3
7.463600E-01
Grade 2-vs-Grade 4
1.276380E-03
Grade 3-vs-Grade 4
4.155100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.193600E-01
Normal-vs-NonDiabetic
7.476600E-01
Diabetic-vs-NonDiabetic
5.529700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.249200E-01
Normal-vs-NoPancreatitis
7.992000E-01
Pancreatitis-vs-NoPancreatitis
1.114980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.510600E-01
Normal-vs-N1
9.926200E-01
N0-vs-N1
8.028500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.993600E-01
Normal-vs-TP53-NonMutant
5.526800E-01
TP53-Mutant-vs-TP53-NonMutant
1.398830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
